APPLICATIONS PUBLISHED 7 JULY 2004
Published: 10-Jan-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
Pierre Fabre Medicament 1434567*
Extended release pharmaceutical compsns containing metformin
Ranbaxy Laboratories 1434568*
Therapeutic biological product and method for formulation of new vascularised bone
CellFactors 1434569*
Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulphonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline
Pfizer 1434570*
Particle immobilised coatings and uses thereof
SurModics 1434571*
Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles
Flamel Technologies 1434572*
Irrigation solution and method for inhibition of pain and inflammation
Omeros Corp 1434573*
Tolterodine metabolites
Bridge Pharma 1434574*
Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
Sepracor 1434575*
Method of alleviating pain
Miller, Kenneth 1434576*
Pyrrolidinone derivatives
UCB 1434577*
Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-HT-6 receptor ligands
Pharmacia & Upjohn 1434578*
Imidazole derivatives as anti-inflammatory agents
Tularik 1434579*
Allylamides useful in the treatment of Alzheimer's disease
Elan Pharmaceuticals 1434580*
3-hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (CETP) inhibitors
Bayer HealthCare 1434581*
Topical compsn containing brucine and the use of the treatment of damaged mammalian skin
T.I.G. Investments 1434582*
N-aroyl piperazine derivatives as orexin receptor antagonists
SmithKline Beecham 1434583*
Compsns and methods of treatment of cancer
Minerva Biotechnologies 1434584*
Alkyne matrix metalloproteinase inhibitors
Warner-Lambert 1434585*
Estrogen/gestagen combination preparation and application thereof
Solvay Pharmaceuticals 1434586*
Pharmaceutical combinations comprising salmetrol and fluticasone propionate for the treatment of asthma
Glaxo Group 1434587*
2-(amino-3,4-dioxo-1-cyclobuten-1-yl)-amino)alkyl)-acid derivatives for the treatment of pain
Wyeth 1434588*
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
Nektar Therapeutics 1434589*
Method for inhibiting the formation of seromas using factor XII
ZymoGenetics 1434590*
Use of fly larvae extracts for the treatment of wounds
Aventis Pharma Deutschland 1434591*
Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer
Agensys 1434592*
Modifications of solid 3-SN-phosphoglycerides
Biomolecular Products 1434593*
Cyclosporin analogues for the treatment of autoimmune diseases
Enanta Pharmaceuticals 1434594*
Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
Procyte Corp 1434595*
Enhancement of immune responses by 4-1BB-binding agents
Mayo Foundation for Medical Education and Research 1434596*
Use of GP130 activators in diabetic neuropathy
Applied Research Systems 1434597*
Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
DeveloGen Aktiengesellschaft fuer entwicklungbiologische Forschung 1434598*
Human 3-relaxin
Howard Florey Institute of Experimental Physiology and Medicine 1434599*
Use of LH in controlled ovarian hyperstimulation
Applied Research Systems 1434600*
Liposome-encapsulated insulin formulations
Aradigm Corp 1434601*
CPG formulations and related methods
Merial 1434602*
Method of treatment using ligand-immunogen conjugates
Purdue Research Foundation 1434603*
4-haloethenylphenyl tropane:serotonin transporter imaging agents
Emory University 1434604*
Process and apparatus for irradiating product pallets
Ion Beam Applications 1434605*
Highly swellable hydrogels with acid centres
BASF 1434606*
Osteophilic implants
Straumann Holding 1434607*
Improved bone graft
Osteotech 1434608*
